
Richard Axel
1946 · American physician, neurobiologist and Nobel laureate
Also on: their science on Newtonpedia
Richard Axel was born in New York City on July 2, 1946, to Polish Jewish immigrants, and grew up in Brooklyn. He attended Stuyvesant High School, a demanding public school in Manhattan, from which he graduated in 1963 alongside several classmates who would also go on to notable careers. He then entered Columbia University, where he received his bachelor's degree in 1967. He trained in medicine at Johns Hopkins University in Baltimore, completing his medical and doctoral studies there in the early 1970s. For readers without medical training, it is worth noting that a medical degree in that era did not settle a person's future path. Students spent years in hospital wards and clinics, and many discovered only then whether they wanted to treat patients or to investigate how the body and disease work. Axel belonged to the second group. According to the accounts available, he was poorly suited to clinical practice and reached an agreement with his department chairman that he would not practice medicine. He found his vocation in research, returned to Columbia later that same year, and was promoted to full professor in 1978.
The world he entered was changing quickly. During the 1970s, techniques of recombinant DNA were developed, allowing scientists to cut, copy and rearrange fragments of genetic material. Molecular biology moved from a specialized laboratory discipline to a central tool of medicine, pharmaceutical research and the biotechnology industry. At the same time, universities began to patent their discoveries more often, creating new tensions between basic research, driven by curiosity, and applied research, aimed at products and profits.
In the late 1970s Axel worked with the microbiologist Saul J. Silverstein and the geneticist Michael H. Wigler on a method known as cotransformation via transfection. Transfection is a procedure that introduces foreign DNA into a host cell so that the cell manufactures particular proteins. Put simply, it is a way of giving a cell new instructions. The technique became fundamental to recombinant DNA work carried out in universities, pharmaceutical firms and biotech companies. The patents, now informally known as the Axel patents, were filed in February 1980 and issued in August 1983. Their financial impact was considerable: at one point they earned Columbia almost one hundred million dollars a year, placing the university near the top of the list of institutions with the greatest licensing revenue. The patents expired in August 2000.
Axel's best-known work came in 1991, when he and Linda Buck published a landmark paper on the sense of smell. They cloned olfactory receptors, meaning they isolated the genes that encode them, and showed that these receptors belong to the family of G protein coupled receptors. Such receptors are proteins embedded in the cell membrane that pick up external signals and pass them to the cell's interior, triggering a response. By analysing rat DNA, the researchers estimated that the mammalian genome must contain at least around a thousand different genes for olfactory receptors. This finding opened the way to the genetic and molecular study of how we smell. Later work by Buck and Axel showed that each olfactory receptor neuron expresses only one kind of receptor, and that the signals from all neurons carrying the same receptor converge on a single glomerulus in the olfactory bulb, a small structure in the brain where smell information is gathered. Smell therefore appears organised in a kind of map. Axel has devoted much of his career to understanding how the brain interprets these signals and which specific regions respond to particular receptors.
His contributions extended beyond neurobiology. His laboratory was among the first to link HIV infection with the CD4 molecule, a receptor on the surface of certain immune cells. He has also trained many leading scientists. Seven of his trainees have become members of the United States National Academy of Sciences, and several have held positions in the investigator and early-career programmes of the Howard Hughes Medical Institute.
In 1983 he was elected a Fellow of the American Academy of Arts and Sciences and a member of the National Academy of Sciences. In 2004 he shared the Nobel Prize in Physiology or Medicine with Linda Buck for their work on olfaction. Further honours followed, including the Golden Plate Award of the American Academy of Achievement in 2005, the Double Helix Medal in 2007, and election as a Foreign Member of the Royal Society in 2014.
Axel's career also includes a controversial chapter. He first met Jeffrey Epstein in the 1980s, through the biotechnology world. In 2007 he spoke admiringly of Epstein, praising his ability to make connections that others could not. Epstein had been convicted of sex offences in 2008. Nevertheless, in 2010 Axel attended a birthday party for Epstein in Paris, and he continued to correspond with him until Epstein's death in 2019. According to the material known as the Epstein files, Axel was a frequent guest at Epstein's home in Manhattan and was invited several times to Epstein's island in the Caribbean. The same records indicate that he acted as a go-between for Epstein with Columbia's admissions and philanthropic offices. Axel maintained contact with Epstein until about three months before Epstein's arrest in 2019.
In February 2026 Axel resigned as co-director of Columbia University's Mortimer B. Zuckerman Mind Brain Behavior Institute. In a statement he described his past association with Epstein as a serious error in judgment and apologised for compromising the trust of his friends, students and colleagues. He also stepped down from his position at the Howard Hughes Medical Institute.
In his personal life, Axel is married to Cornelia Bargmann, a scientist who is also a pioneer in the study of olfaction. He was previously married to Ann Axel, a social worker at Columbia University Medical Center. As a teenager he played basketball, drawing on his considerable height.
His legacy is twofold. On the one hand, his work with Linda Buck transformed the understanding of smell, presenting it as a system whose genetic and neural organisation can be deciphered, and laid foundations for a line of research that remains active. On the other hand, his recent history is a reminder that scientific reputation does not always withstand scrutiny of personal and professional relationships. His scientific achievements remain part of the history of biology, while his links with Epstein are part of the public memory of his life.
Contributions
- Olfactory receptors: cloned in 1991, they belong to the family of G protein coupled receptors.
- Organisation of smell: each olfactory neuron expresses a single type of receptor, and its signals converge on one glomerulus.
- Transfection technique: a cotransformation method that allows foreign DNA to be introduced into cells to produce proteins.
- Link with HIV: his laboratory helped connect HIV infection with the immune receptor CD4.
Curiosities and anecdotes
Classmates at school
Axel graduated from Stuyvesant High School in 1963 alongside classmates who later distinguished themselves in very different fields, including actor Ron Silver and political historian Allan Lichtman.
A very profitable patent
The patents covering the transfection technique, known as the “Axel patents”, earned Columbia University almost 100 million dollars a year at one point.
Sources
Original Medicapedia text based on:
Last updated: 5 November 2026 · How Medicapedia is made
A project by Alejandro Rosàs Navarro, family physician and specialist in preventive medicine and public health. Spotted a mistake? Write to info@medicapedia.org.